NCT05133804View on ClinicalTrials.gov

Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD

PHASE2RecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

December 1, 2025

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Methylphenidate

Ritalin 10mg

DRUG

Reboxetine

Reboxetine 4mg

DRUG

Placebo

Placebo matched to Reboxetine

DRUG

Placebo

Placebo matched to Ritalin

Trial Locations (3)

Unknown

RECRUITING

Emek Medical Center, Afula

RECRUITING

University of Haifa, Haifa

RECRUITING

Lev HaSharon Mental Health Center, Netanya

All Listed Sponsors
lead

University of Haifa

OTHER